Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
Zachary S Wallace,
Jeffrey A Sparks,
Michael DiIorio,
Naomi J Patel,
Kathleen MM Vanni,
Emily Kowalski,
Grace Qian,
Claire E Cook,
Susan Y Ritter
Affiliations
Zachary S Wallace
Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA
Jeffrey A Sparks
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women`s Hospital, Boston, Massachusetts, USA
Michael DiIorio
Department of Medicine, Brigham and Women`s Hospital, Boston, Massachusetts, USA
Naomi J Patel
Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA
Kathleen MM Vanni
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women`s Hospital, Boston, Massachusetts, USA
Emily Kowalski
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women`s Hospital, Boston, Massachusetts, USA
Grace Qian
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women`s Hospital, Boston, Massachusetts, USA
Claire E Cook
Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA
Susan Y Ritter
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women`s Hospital, Boston, Massachusetts, USA
